株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ニードルフリー・ドラッグデリバリ装置の世界市場:市場規模・シェア・動向・将来予測、用途別・技術別 (ジェット式注射器、吸入器、経皮パッチ、最新鋭ニードルフリー)・部門別

Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 358156
出版日 ページ情報 英文 90 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.21円で換算しております。
Back to Top
ニードルフリー・ドラッグデリバリ装置の世界市場:市場規模・シェア・動向・将来予測、用途別・技術別 (ジェット式注射器、吸入器、経皮パッチ、最新鋭ニードルフリー)・部門別 Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 - 2025
出版日: 2018年12月18日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界のニードルフリー・ドラッグデリバリ (薬剤送達) 装置の市場について分析し、技術・製品の概要や市場の基本構造、主な市場促進・抑制要因、全体的な市場動向の見通し (過去4年間・今後8年間分)、技術別・用途別・地域別の詳細動向、市場競争情勢、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 分析対象

第4章 エグゼクティブ・サマリー

第5章 ニードルフリー・ドラッグデリバリ装置市場:産業概略

  • 市場変数の分析
  • 市場促進要因の分析
    • 感染症の発症件数の増加
    • 薬剤の自己投与ニーズの増大
    • 最新鋭のニードルフリー・ドラッグデリバリ装置の導入
    • ペインフリーな薬剤送達手段の巨大需要
  • 市場抑制要因の分析
    • ニードルフリー技術のコストの高さ
  • 事業環境分析ツール
    • SWOT分析、要因別 (政治的・法的、経済的、技術的)
    • ポーターのファイブフォース分析

第6章 市場競争・ベンダー情勢

  • 市場参入企業の分類
    • 市場リーダー
    • イノベーター
  • 戦略展開状況と成果の分析

第7章 ニードルフリー・ドラッグデリバリ装置市場:技術別分析

  • 事業分析:技術別
  • ジェット式注射器
  • 吸入器
  • 経皮パッチ
  • 新たなニードルフリー技術

第8章 ニードルフリー・ドラッグデリバリ装置市場:用途別分析

  • 事業分析:用途別
  • ワクチン送達
  • 疼痛管理
  • インスリン送達
  • 小児向け注射器
  • その他

第9章 ニードルフリー・ドラッグデリバリ装置市場:地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国)
  • アジア太平洋地域 (中国、インド、日本)
  • ラテンアメリカ (メキシコ、ブラジル)
  • 中東・アフリカ (南アフリカ)

第10章 企業プロファイル

  • 主要企業のプロファイル
    • Antares Pharma
      • 企業概要
      • 財務実績
      • 製品の比較分析
      • 戦略展開状況
    • INJEX Pharma AG
    • Verdict Media Limited
    • 3M
    • PharmaJet
    • zonenix
    • Inovio Pharmaceuticals, Inc.
    • Valeritas, Inc
    • PenJet

第11章 提言/結論

図表

List of Tables

  • Table 1 Country share estimation
  • Table 2 North America needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 3 North America needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 4 U.S. needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 5 U.S. needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 6 Canada needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 7 Canada needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 8 Europe needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 9 Europe needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 10 Germany needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 11 Germany needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 12 U.K. needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 13 U.K. needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 14 Asia Pacific needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 15 Asia Pacific needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 16 China needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 17 China needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 18 India needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 19 India needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 20 Japan needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 21 Japan needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 22 Latin America needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 23 Latin America needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 24 Mexico needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 25 Mexico needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 26 Brazil needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 27 Brazil needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 28 MEA needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 29 MEA needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)
  • Table 30 South Africa needle-free drug delivery devices market, by technology, 2014 - 2025 (USD Million)
  • Table 31 South Africa needle-free drug delivery devices market, by application, 2014 - 2025 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Value chain-based sizing & forecasting
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Components: TAM
  • Fig. 6 Information procurement
  • Fig. 7 Primary interviews, by sources
  • Fig. 8 Primary interviews, by region
  • Fig. 9 Needle-free drug delivery devices market revenues, 2017 (USD Millions)
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Needle-free drug delivery devices market - SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market participant categorization
  • Fig. 16 Strategy framework analysis, 2017
  • Fig. 17 Needle-free drug delivery devices market technology outlook: Key takeaways
  • Fig. 18 Needle-free drug delivery devices market: Technology movement analysis
  • Fig. 19 Global jet injectors market, 2014 - 2025 (USD Million)
  • Fig. 20 Global inhaler technology market, 2014 - 2025 (USD Million)
  • Fig. 21 Global transdermal patch technology market, 2014 - 2025 (USD Million)
  • Fig. 22 Global novel needle-free technologies market, 2014 - 2025 (USD Million)
  • Fig. 23 Needle-free drug delivery devices market application outlook: Key takeaways
  • Fig. 24 Needle-free drug delivery devices market: Application movement analysis
  • Fig. 25 Global vaccine delivery market, 2014 - 2025 (USD Million)
  • Fig. 26 Global pain management market, 2014 - 2025 (USD Million)
  • Fig. 27 Global insulin delivery market, 2014 - 2025 (USD Million)
  • Fig. 28 Global pediatric injections market, 2014 - 2025 (USD Million)
  • Fig. 29 Global others market, 2014 - 2025 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional outlook, 2014 - 2025 (USD Million)
  • Fig. 32 North America needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 33 U.S. needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 34 Canada needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 35 Europe needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 36 Germany Needle-Free Drug Delivery Devices Market, 2014 - 2025 (USD Million)
  • Fig. 37 U.K. needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 38 Asia Pacific needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 39 China needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 40 India needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 41 Japan needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 42 Latin America needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 43 Mexico needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 44 Brazil needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 45 MEA needle-free drug delivery devices market, 2014 - 2025 (USD Million)
  • Fig. 46 South Africa needle-free drug delivery devices market, 2014 - 2025 (USD Million)
目次
Product Code: 978-1-68038-879-4

The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

Further key findings from the report suggest:

Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications

Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients

North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies

For instance, In May 2018, U.S. Congress approved "right to try" bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs

The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector

Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free

Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company

Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.

Table of Contents

Chapter 1 Report Scope

  • 1.1 Segment Market Scope
  • 1.2 Regional Scope
  • 1.3 Estimates & Forecast Timeline

Chapter 2 Research Methodology

  • 2.1 Model Details
    • 2.1.1 Regression and variable analysis
    • 2.1.2 Total addressable market (TAM)
  • 2.2 Information Procurement
  • 2.3 List Of Primary Sources
    • 2.3.1 Purchased database:
    • 2.3.2 GVR's internal database
  • 2.4 Primary Interview Breakup
    • 2.4.1 Data for primary interviews, by sources
    • 2.4.2 Data for primary interviews, by region
  • 2.5 List Of Secondary Sources

Chapter 3 Report Objectives

  • 3.1 Objectives

Chapter 4 Executive Summary

  • 4.1 Market Summary

Chapter 5 Needle-Free Drug Delivery Devices Market: Industry Outlook

  • 5.1 Market Variable Analysis
  • 5.2 Market Driver Analysis
    • 5.2.1 Increasing incidences of infectious diseases
    • 5.2.2 Rising need of self-administration of the drug
    • 5.2.3 Introduction of technologically advanced needle-free drug delivery devices
    • 5.2.4 High demand for pain-free delivery
  • 5.3 Market Restraints Analysis
    • 5.3.1 High cost of needle-free technology
  • 5.4 Business Environment Analysis Tools
    • 5.4.1 Needle-Free Drug Delivery Devices Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 5.4.2 Porter's Five Forces Analysis

Chapter 6 Competitive & Vendor Landscape

  • 6.1 Market Participation Categorization
    • 6.1.1 Market leader
    • 6.1.2 Innovators
  • 6.2 Strategic Initiatives & Outcome Analysis

Chapter 7 Needle-Free Drug Delivery Devices Market: Technology Analysis

  • 7.1 Technology Business Analysis
  • 7.2 Jet Injectors
    • 7.2.1 jet injectors estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.3 Inhaler technology
    • 7.3.1 Inhaler technology market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.4 Transdermal Patch Technology
    • 7.4.1 Transdermal Patch Technology market estimates and forecasts, 2014 - 2025 (USD Million)
  • 7.5 Novel Needle-Free Technologies
    • 7.5.1 Novel Needle-Free Technologies market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8 Needle-Free Drug Delivery Devices Market: Application Analysis

  • 8.1 Application Business Analysis
  • 8.2 Vaccine Delivery
    • 8.2.1 Vaccine Delivery estimates and forecasts, 2014 - 2025 (USD Million)
  • 8.3 Pain Management
    • 8.3.1 Pain Management market estimates and forecasts, 2014 - 2025 (USD Million)
  • 8.4 Insulin Delivery
    • 8.4.1 Insulin Delivery Technology market estimates and forecasts, 2014 - 2025 (USD Million)
  • 8.5 Pediatric Injections
    • 8.5.1 Pediatric Injections market estimates and forecasts, 2014 - 2025 (USD Million)
  • 8.6 Others
    • 8.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 9 Needle-Free Drug Delivery Devices Market: By Technology, By Application, and Regional Analysis

  • 9.1 North America
    • 9.1.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.1.3 Canada
      • 9.1.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 9.2 Europe
    • 9.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.2.2 Germany
      • 9.2.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.2.3 U.K.
      • 9.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.3.2 China
      • 9.3.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.3.3 India
      • 9.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.3.4 Japan
      • 9.3.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Market Estimates And Forecasts, 2014 - 2025 (Usd Million)
    • 9.4.2 Mexico
      • 9.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.4.3 Brazil
      • 9.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 9.5 MEA
    • 9.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 9.5.2 South Africa
      • 9.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Key Company Profiles
    • 10.1.1 Antares Pharma
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 INJEX Pharma AG
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Verdict Media Limited
      • 10.1.3.1 Company overview
      • 10.1.3.2 Product benchmarking
      • 10.1.3.3 Strategic initiatives
    • 10.1.4 3M
      • 10.1.4.1 Company overview
      • 10.1.4.2 Product benchmarking
      • 10.1.4.3 Strategic initiatives
    • 10.1.5 PharmaJet
      • 10.1.5.1 Company overview
      • 10.1.5.2 Product benchmarking
      • 10.1.5.3 Strategic initiatives
    • 10.1.6 zonenix
      • 10.1.6.1 Company overview
      • 10.1.6.2 Product benchmarking
      • 10.1.6.3 Strategic initiatives
    • 10.1.7 Inovio Pharmaceuticals, Inc.
      • 10.1.7.1 Company overview
      • 10.1.7.2 Product benchmarking
      • 10.1.7.3 Strategic initiatives
    • 10.1.8 Valeritas, Inc
      • 10.1.8.1 Company overview
      • 10.1.8.2 Product benchmarking
      • 10.1.8.3 Strategic initiatives
    • 10.1.9 PenJet
      • 10.1.9.1 Company overview
      • 10.1.9.2 Product benchmarking
      • 10.1.9.3 Strategic initiatives

Chapter 11 Recommendations/Conclusion

  • 11.1 Recommendations
  • 11.2 Conclusion
Back to Top